Donate Connect
SEARCH

FOP News

Ipsen Receives Complete Response Letter from U.S. FDA

Posted by · December 23, 2022 6:55 PM
Read more Share

Tell the FDA What It's Like to Live With FOP

Posted by · December 13, 2022 1:17 PM
Read more Share

Regeneron OPTIMA Phase III Trial Now Recruiting

Posted by · December 09, 2022 6:50 PM
Read more Share

IFOPA-funded Gene Therapy Research Published in Nature Communications

Posted by · November 17, 2022 1:17 PM
Read more Share

Announcement from BioCryst Pharmaceuticals About BCX9250

Posted by · November 01, 2022 7:04 AM
Read more Share

IPSEN Publishes Burden of Illness Study and Releases Plain Language Summary

Posted by · October 31, 2022 1:12 PM
Read more Share

FDA Advisory Committee Meeting for Palovarotene Capsules Postponed

Posted by · October 25, 2022 4:23 PM
Read more Share

Ipsen's FOP Natural History Study Published in the Genetics in Medicine Journal

Posted by · September 30, 2022 3:49 PM
Read more Share

18 FOP and HO Sessions and Posters Featured at the ASBMR 2022 Annual Meeting

Posted by · September 24, 2022 3:29 PM
Read more Share

BioCryst Pharmaceuticals Granted Orphan Drug Designation from U.S. FDA for BCX9250

Posted by · September 01, 2022 9:04 AM
Read more Share

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise
Sign in with Facebook, Twitter or email.
Site by Mosaic • Created with NationBuilder
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter

X